This study was intended to investigate the pre- and postoperative profile of seizures in the patients with cerebral arteriovenous malformations (AVMs). The patients consisted of 46 consecutive cases with supratentorial AVMs operated on from May 1987 to May 1993. Their postoperative mean follow-up duration was 60 months. The overall incidences of seizure were 50% preoperatively and 52% postoperatively, and the incidence of intractable seizure was 15% in both pre- and postoperative period. The presence of preoperative seizure and large AVM size were significant indicators of high risk of postoperative seizures (P < 0.05). About 70% of the patients with preoperative seizures showed seizures postoperatively, while those without preoperative seizures developed seizures postoperatively in 35%. Regarding postoperative intractable seizures, 57% of the group with preoperative intractable seizures remained intractable postoperatively. In conclusion, removal of AVMs did not change the overall incidence of seizures, and patients with large sized AVMs and preoperative seizure had a higher possibility of postoperative seizures.

Download full-text PDF

Source

Publication Analysis

Top Keywords

seizures
10
patients cerebral
8
cerebral arteriovenous
8
arteriovenous malformations
8
pre- postoperative
8
seizures patients
8
preoperative seizure
8
postoperative seizures
8
preoperative seizures
8
seizures postoperatively
8

Similar Publications

Background: Glucose transporter 1 deficiency syndrome (Glut1DS) was initially reported by De Vivo and colleagues in 1991. This disease arises from mutations in the SLC2A1 and presents with a broad clinical spectrum. It is a treatable neuro-metabolic condition, where prompt diagnosis and initiation of ketogenic dietary therapy can markedly enhance the prognosis.

View Article and Find Full Text PDF

[Lu]Lu-DOTATATE is a newly trending acceptable therapy in recurrent/residual meningioma with good safety. However, recognizing any possible side effects in this special population would be helpful for better management and individualization of this useful treatment. Although the seizure has been previously reported in a few cases after [Lu]Lu-DOTATATE therapy in recurrent meningioma, the acute onset of seizure in these patients, early after therapeutic radioligand administration, is not reported to the best of our knowledge.

View Article and Find Full Text PDF

Objective: This investigation aimed to elucidate alterations in metabolic brain network connectivity in drug-resistant mesial temporal lobe epilepsy (DR-MTLE) patients, relating these changes to varying surgical outcomes.

Methods: A retrospective cohort of 87 DR-MTLE patients who underwent selective amygdalohippocampectomy was analyzed. Patients were categorized based on Engel surgical outcome classification into seizure-free (SF) or non-seizure-free (NSF) groups.

View Article and Find Full Text PDF

Background: The safe timing window for surgery during the acute phase of inflammation due to traumatic brain injury (TBI) has not been studied extensively. We aimed to elucidate the relationship between the timing of surgery and changes in perioperative serum levels of inflammatory cytokines and factors associated to optimize TBI management in low-middle-income countries.

Methods: A prospective cohort study was conducted among TBI Patients with depressed skull fractures with a GCS > 8 operated at different timing from injury and followed up peri-operatively.

View Article and Find Full Text PDF

Here we presented a rare case of Lafora disease with neuropathy, ataxia and progression of symptoms into type one DM, GTCS and myoclonus during years. We believe that it is important to keep the diagnosis of Lafora disease in mind in every child presenting with myoclonus especially when mental and cerebellar deficits develop as well. Keywords: Drug-resistant seizure, Ataxia, Myoclonic jerky movements, Lafora.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!